Concomitantly, statins reduce circulating levels of inflammatory markers such as C-reactive protein (CRP), leading to a prognostic benefit both in apparently healthy patients [23] and in patients with acute coronary syndrome (ACS) [24]. The gene discussed is CRP; the disease is acute coronary syndrome.